You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

Tolterodine tartrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for tolterodine tartrate and what is the scope of freedom to operate?

Tolterodine tartrate is the generic ingredient in three branded drugs marketed by Upjohn, Ajanta Pharma Ltd, Amta, Aurobindo Pharma Usa, Hetero Labs Ltd Iii, Inventia Hlthcare, Teva Pharms Usa, Torrent, Apotex Corp, Elysium, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Macleods Pharms Ltd, Mylan Pharms Inc, Unichem, and Unique, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for tolterodine tartrate. Twenty suppliers are listed for this compound. There are two tentative approvals for this compound.

Drug Prices for tolterodine tartrate

See drug prices for tolterodine tartrate

Drug Sales Revenue Trends for tolterodine tartrate

See drug sales revenues for tolterodine tartrate

Recent Clinical Trials for tolterodine tartrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Institute of Acupuncture, Moxibustion and MeridianN/A
RenJi HospitalN/A
University of California, San FranciscoPhase 4

See all tolterodine tartrate clinical trials

Generic filers with tentative approvals for TOLTERODINE TARTRATE
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up2MGTABLET; ORAL
⤷  Sign Up⤷  Sign Up1MGTABLET; ORAL
⤷  Sign Up⤷  Sign Up2MGTABLET; ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for tolterodine tartrate
Medical Subject Heading (MeSH) Categories for tolterodine tartrate
Anatomical Therapeutic Chemical (ATC) Classes for tolterodine tartrate
Paragraph IV (Patent) Challenges for TOLTERODINE TARTRATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DETROL LA Extended-release Capsules tolterodine tartrate 2 mg and 4 mg 021228 1 2007-07-30

US Patents and Regulatory Information for tolterodine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Inventia Hlthcare TOLTERODINE TARTRATE tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 204562-002 Aug 19, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent TOLTERODINE TARTRATE tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 203016-002 Aug 11, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amta TOLTERODINE TARTRATE tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 213858-002 Feb 2, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for tolterodine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 ⤷  Sign Up ⤷  Sign Up
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 ⤷  Sign Up ⤷  Sign Up
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.